Home > Healthcare > Medical Devices > Diagnostic Devices > positron emission tomography market
Get a free sample of Positron Emission Tomography (PET) Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Positron Emission Tomography (PET) Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The market features established companies such as Siemens Healthineers, GE Healthcare, Koninklijke Philips, and Canon Medical Systems Corporation as key players. These companies focus on technological advancements, strategic partnerships, and geographical expansion to maintain their market positions. The competitive landscape is characterized by significant investments in research and development to enhance imaging quality, reduce radiation exposure, and improve diagnostic accuracy. Market players are also expanding their product portfolios through mergers and acquisitions, while simultaneously developing integrated solutions that combine PET with other imaging modalities like CT and MRI. Regional expansion, particularly in emerging markets, and the development of cost-effective systems remain primary competitive strategies.
Some of the eminent market participants operating in the positron emission tomography industry include:
The positron emission tomography industry was valued at USD 2.1 billion in 2024 and is projected to grow at a 6.1% CAGR from 2025 to 2034, driven by advancements in imaging technology and increasing demand for diagnostic tools.
The full ring PET scanner segment generated USD 1.7 billion in 2024 and is expected to grow significantly during the forecast period due to its effectiveness in clinical applications such as oncology, cardiology, neurology, and psychiatry.
The U.S. positron emission tomography market recorded USD 713.8 million in 2024 and is anticipated to witness substantial growth, fueled by the rising prevalence of cancer and cardiovascular diseases.
Key players in the market include Canon Medical Systems Corporation, CMR Naviscan, Fujifilm Holdings Corporation, GE Healthcare, Koninklijke Philips, Mediso, Minfound Medical Systems, Molecubes, Neusoft Corporation, Oncovision, Positron, and Radialis.